GlassScriptPhysician profile
Gabrielle Beth Laurenti
NPI 1093178204
$2,744.75
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,215 · 2020: $466 · 2021: $658 · 2022: $204 · 2023: $186 · 2024: $15.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $797.86 | 2019-2022 | |
| Stryker Corporation | $716.39 | 2019-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $249.02 | 2019-2023 | Jublia |
| Integra Lifesciences Corporation | $212.97 | 2020 | |
| Horizon Therapeutics Plc | $172.70 | 2019-2021 | |
| Derma Sciences, INC. | $146.89 | 2019 | |
| Treace Medical Concepts, INC. | $122.72 | 2021 | |
| Medtronic Vascular, INC. | $121.18 | 2019 | |
| Kerecis Limited | $51.77 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Zyla Life Sciences, INC. | $49.37 | 2020 | |
| Glaxosmithkline, LLC. | $29.24 | 2023 | Trelegy Ellipta, Shingrix |
| Cook Medical LLC | $23.34 | 2021 | |
| Advanced Oxygen Therapy INC. | $19.52 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.46 | 2023 | Seglentis |
| Bioventus LLC | $15.32 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gabrielle Laurenti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.